Supplementary Figure S2 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Baseline CD47 expression by flow cytometry in colorectal cancer cell lines (A) and in DLBCL cell lines (B).
Supplementary Figure S2 from Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies | Synapse